Another Corona vaccine has been approved in Pakistan, the Drug Regulatory Authority of Pakistan (DRAP) has approved the emergency use of Chinese-made corona vaccine CanSino Biologics.
Pakistan, largely reliant on the GAVI/WHO COVAX initiative for poorer nations, has also allowed private companies to import coronavirus vaccines and has agreed to exempt such imports from price caps.
“Yes, correct,” Sultan texted Reuters after being asked if the Drug Regulation Authority had approved the vaccine.
China’s Sinopharm, AstraZeneca and Russia’s Sputnik V have also received authorisation.
Pakistan is the second country to approve CanSinoBio after Mexico.
Mexico has signed a deal with CanSino for at least 8 million doses. Pakistan, according to Sultan, could receive “in the range of tens of millions” of doses.
CanSinoBIO last week released interim efficacy results from a multi-country trial, which included Pakistan, showing 65.7% efficacy in preventing symptomatic coronavirus cases and a 90.98% success rate in stopping severe infections.
In the Pakistani subset, efficacy of the CanSinoBIO vaccine at preventing symptomatic cases was 74.8% and 100% at preventing severe disease.
The decision to allow commercial imports of the vaccine with an exemption on upper price caps has sparked criticism.